Skip to main content
. Author manuscript; available in PMC: 2015 Feb 26.
Published in final edited form as: AIDS Behav. 2013 Oct;17(8):2808–2815. doi: 10.1007/s10461-012-0401-0

Table 1.

cART Breakdown

CPE rank Participants prescribed %
Truvada® (emtricitabine and tenofovir) 3, 1 64
Norvir® ritonavir 1 48
Reyataz® atazanavir 2 44
Kaletra lopinavir + ritonavir 3 40
Epzicom® abacavir + lamivudine 3, 2 32
Viread® tenofovir 1 12
Prezista® darunavir 3 12
Isentress® raltegravir 3 12
Lexiva® fosamprenavir 3 8
Epivir® lamivudine 2 4
Combivir® lamivudine + zidovudine 4, 2 4
Intelence® etravirine 2 4
Retrovir® zidovudine 4 4
Trizivir® abacavir + lamivudine + zidovudine 3 4

Medications with CNS Penetration mean 7.8 (±2.2)